Luis Gerardo Alvarez, MD | |
801 N 29th St, Billings, MT 59101-0905 | |
(406) 238-2500 | |
Not Available |
Full Name | Luis Gerardo Alvarez |
---|---|
Gender | Male |
Speciality | Cardiac Electrophysiology |
Experience | 38 Years |
Location | 801 N 29th St, Billings, Montana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417951922 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Billings Clinic | Billings, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Billings Clinic | 6002993516 | 659 |
News Archive
Walking past a corner bakery, you may find yourself drawn in by the fresh smell of sweets wafting from the front door. You're not alone: The knowledge that humans make decisions based on their noses has led major brands like Cinnabon and Panera Bread to pump the scents of baked goods into their restaurants, leading to big spikes in sales.
Researchers in the Campbell Clinic Department of Orthopaedic Surgery at the University of Tennessee Health Science Center in Memphis, Tennessee, presented a paper that indicates a new polymer under study for applications in joint reconstruction can significantly reduce up to seven times the harmful chemicals formed as a result of the presence of wear particle debris in the body.
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
Entity Name | Daniels Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750459632 PECOS PAC ID: 4880685965 Enrollment ID: O20040518001546 |
News Archive
Walking past a corner bakery, you may find yourself drawn in by the fresh smell of sweets wafting from the front door. You're not alone: The knowledge that humans make decisions based on their noses has led major brands like Cinnabon and Panera Bread to pump the scents of baked goods into their restaurants, leading to big spikes in sales.
Researchers in the Campbell Clinic Department of Orthopaedic Surgery at the University of Tennessee Health Science Center in Memphis, Tennessee, presented a paper that indicates a new polymer under study for applications in joint reconstruction can significantly reduce up to seven times the harmful chemicals formed as a result of the presence of wear particle debris in the body.
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
Entity Name | Billings Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326104845 PECOS PAC ID: 6002993516 Enrollment ID: O20080430000212 |
News Archive
Walking past a corner bakery, you may find yourself drawn in by the fresh smell of sweets wafting from the front door. You're not alone: The knowledge that humans make decisions based on their noses has led major brands like Cinnabon and Panera Bread to pump the scents of baked goods into their restaurants, leading to big spikes in sales.
Researchers in the Campbell Clinic Department of Orthopaedic Surgery at the University of Tennessee Health Science Center in Memphis, Tennessee, presented a paper that indicates a new polymer under study for applications in joint reconstruction can significantly reduce up to seven times the harmful chemicals formed as a result of the presence of wear particle debris in the body.
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Luis Gerardo Alvarez, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Luis Gerardo Alvarez, MD 801 N 29th St, Billings, MT 59101-0905 Ph: (406) 238-2500 |
News Archive
Walking past a corner bakery, you may find yourself drawn in by the fresh smell of sweets wafting from the front door. You're not alone: The knowledge that humans make decisions based on their noses has led major brands like Cinnabon and Panera Bread to pump the scents of baked goods into their restaurants, leading to big spikes in sales.
Researchers in the Campbell Clinic Department of Orthopaedic Surgery at the University of Tennessee Health Science Center in Memphis, Tennessee, presented a paper that indicates a new polymer under study for applications in joint reconstruction can significantly reduce up to seven times the harmful chemicals formed as a result of the presence of wear particle debris in the body.
A stem cell therapy previously shown to reduce inflammation in the critical time window after traumatic brain injury also promotes lasting cognitive improvement, according to preclinical research led by Charles Cox, M.D., at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
Charles Wittnam, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500 | |
Phillip Embury Griffin, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2938 Rockrim Ln, Billings, MT 59102 Phone: 406-259-7582 | |
Megan B Littlefield, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Charles Mcclave, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2900 12th Ave N, Suite 160w, Billings, MT 59101 Phone: 406-237-8500 Fax: 406-237-8501 | |
Karen C. Klee, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Brock P. Whittenberger, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Benjamin Girton Plank, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 |